CDP Venture Capital

CDP Venture Capital, established in 2015 and based in Rome, Italy, is a prominent venture capital investment firm dedicated to fostering innovation and economic development within the country. The firm aims to enhance the venture capital ecosystem by investing in startups and growth companies across a diverse range of sectors, including consumer products, energy, healthcare, information technology, automotive, fashion, food, fintech, insur-tech, advanced manufacturing, agriculture materials, education, big data, life sciences, financial services, software-as-a-service, virtual reality, artificial intelligence, and machine learning. By prioritizing these industries, CDP Venture Capital seeks to create sustainable growth and support the overall development of Italy's entrepreneurial landscape.

Alessandro Angeletti

Investment Manager

Hagaj Badash

Investment Manager

Cristina Bini

Senior Partner

Filippo Bosco Ph.D

Partner

Simona Corno

Senior Partner

Lorenzo Franchini

Senior Partner - Co-Head of the Evolution Fund

Daniele Genovesi

Senior Partner and Fund Manager

francesco grassi

Investment Manager

Elisa Grasso

Senior Investment Manager

Federico Lanciano

Partner

Niccolò Mussi

Investment Manager

Davide Opromolla

Senior Investment Manager

Claudia Pingue

Senior Partner

Matteo Pozzi

Partner, Head of InfraTech Portfolio

Ersilia Rendola

Partner

Davide Santi

Senior Investment Manager

Mario Scuderi

Partner

Giacomo Valentini

Senior Partner

Alessandro Vasconi

Associate

Rita Verderosa

Partner

Rebecca d'aloja

Senior Associate

Past deals in Dietary Supplements

ExoLab Italia

Series A in 2025
ExoLab Italia is a biotechnology company focused on developing innovative products derived from plant exosomes sourced from organic farming. The company operates a laboratory dedicated to research, innovation, and the production of plant exosome extracts, which are utilized in dermocosmetic, nutraceutical, and life science applications. ExoLab Italia offers bioavailable supplements that retain the complete phytocomplex found in plants, presenting a novel approach to health prevention and treatment. Additionally, the company provides specialized consultancy services to assist clients in creating unique research projects tailored to their specific requirements, culminating in the development of optimal product formulations supported by scientific documentation.

Sestre

Venture Round in 2024
Sestre is an online retailer specializing in nutraceutical supplements and wellness products, with a particular focus on extracts derived from Mediterranean cuisine. The company aims to address hormonal issues affecting female fertility and improve quality of life for women, especially those in the early stages of pregnancy. Sestre's product formulations are informed by research on chronic diseases and hormonal dysfunctions, filling a gap in therapeutic options for conditions that lack effective treatments. By offering a range of nutrition and health-focused products, Sestre supports individuals seeking to enhance their well-being through informed dietary choices.

MyLab Nutrition

Seed Round in 2021
MyLab Nutrition Group specializes in the development and distribution of high-quality dietary supplements under its brands, including T-Rex Integratori, Nutracle, Suprapet, and MyLab Nutrition. The company employs a technologically innovative approach to create supplements that are made in Italy. Its primary goal is to enhance individual well-being through targeted nutrition, which is achieved by offering ready-made supplements alongside an AI-driven digital consultancy. This interactive platform assesses individual nutritional needs and recommends tailored supplement solutions, allowing customers to address specific dietary gaps effectively. Through this personalized service, MyLab Nutrition aims to empower individuals to optimize their health and well-being.

Molecular Research

Seed Round in 2020
Molecular Research Srl, based in Maglie, Italy, is a contract research organization that specializes in the research and development of molecules across various sectors, including nutraceuticals, food, dietary supplements, and pharmaceuticals. The company provides comprehensive services that encompass the development of new molecules in the preclinical phase, as well as the repurposing and repositioning of existing compounds. By offering expertise in pharmaceutical analytical chemistry, Molecular Research supports pharmaceutical companies in drug design and profiling, thereby facilitating advancements in therapeutic options and product formulation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.